Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
Open Access
- 1 September 1999
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 230 (3), 309
- https://doi.org/10.1097/00000658-199909000-00004
Abstract
There is a need for clearly defined and widely applicable clinical criteria for the selection of patients who may benefit from hepatic resection for metastatic colorectal cancer. Such criteria would also be useful for stratification of patients in clinical trials for this disease. Clinical, pathologic, and outcome data for 1001 consecutive patients undergoing liver resection for metastatic colorectal cancer between July 1985 and October 1998 were examined. These resections included 237 trisegmentectomies, 394 lobectomies, and 370 resections encompassing less than a lobe. The surgical mortality rate was 2.8%. The 5-year survival rate was 37%, and the 10-year survival rate was 22%. Seven factors were found to be significant and independent predictors of poor long-term outcome by multivariate analysis: positive margin (p = 0.004), extrahepatic disease (p = 0.003), node-positive primary (p = 0.02), disease-free interval from primary to metastases 1 (p = 0.0004), largest hepatic tumor >5 cm (p = 0.01), and carcinoembryonic antigen level >200 ng/ml (p = 0.01). When the last five of these criteria were used in a preoperative scoring system, assigning one point for each criterion, the total score was highly predictive of outcome (p Resection of hepatic colorectal metastases may produce long-term survival and cure. Long-term outcome can be predicted from five criteria that are readily available for all patients considered for resection. Patients with up to two criteria can have a favorable outcome. Patients with three, four, or five criteria should be considered for experimental adjuvant trials. Studies of preoperative staging techniques or of adjuvant therapies should consider using such a score for stratification of patients.Keywords
This publication has 39 references indexed in Scilit:
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.JCI Insight, 1997
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995
- Perioperative Blood Transfusion and Determinants of Survival After Liver Resection for Metastatic Colorectal CarcinomaAnnals of Surgery, 1992
- One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinantsBritish Journal of Surgery, 1991
- A Prospective Randomized Trial of Regional Versus Systemic Continuous 5-Fluorodeoxyuridine Chemotherapy in the Treatment of Colorectal Liver MetastasesAnnals of Surgery, 1987
- Hepatic Resection for Colorectal Liver MetastasesAnnals of Surgery, 1987
- A new technique for hepatic infusional chemotherapySeminars in Surgical Oncology, 1986
- Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancerCancer, 1985
- Multivariate Analysis of a Personal Series of 247 Consecutive Patients with Liver Metastases from Colorectal CancerAnnals of Surgery, 1984